Evidence map›Paper›PMID 39240901›Full record

ArticlePloS one2024

Are children of key population individuals at higher risk of HIV than other children? Results from a multi-country analysis of routine program data.

Caterina Casalini, Sarah Yeiser, Hanna Amanuel, Amy Gottlieb, Chris Akolo, Madje Koffivi Toovi, Dismas Gashobotse, Pablo Mabanza, Bernard Ogwang, Sandra Georges and 2 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Caterina CasaliniFHI 360, HIV Department, Washington, DC, United States of America.ORCID 0000-0003-2684-6269
Sarah YeiserGlobal Health Security and Diplomacy-U.S. President's Emergency Plan for AIDS Relief, formerly at United States Agency for International Development, Washington, DC, United States of America.
Hanna AmanuelGlobal Health Security and Diplomacy-U.S. President's Emergency Plan for AIDS Relief, formerly at United States Agency for International Development, Washington, DC, United States of America.
Amy GottliebFHI 360, HIV Department, Washington, DC, United States of America.
Chris AkoloFHI 360, HIV Department, Washington, DC, United States of America.
Madje Koffivi TooviFHI 360, HIV Department, Lomé, Togo.
Dismas GashobotseFHI 360, HIV Department, Bujumbura, Burundi.
Pablo MabanzaFHI 360, HIV Department, Lubumbashi, Democratic Republic of the Congo.
Bernard OgwangFHI 360, HIV Department, Dar es Salaam, Tanzania.
Sandra GeorgesFHI 360, HIV Department, Abidjan, Côte d'Ivoire.
Natasha MackFHI 360, Scientific, Technical, and Evidence Advancement, Durham, NC, United States of America.
Meena SrivastavaGlobal Health Security and Diplomacy-U.S. President's Emergency Plan for AIDS Relief, formerly at United States Agency for International Development, Washington, DC, United States of America.

Funding

Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

introductionChildren of key population individuals (CPK) often face the same stigma and discrimination as their parents, limiting their access to HIV services. The Meeting Targets and Maintaining Epidemic Control project analyzed pediatric HIV testing data from project-supported sites to better understand risk among CKP and improve comprehensive prevention, testing, and treatment for KP families.

methodsWe conducted a retrospective analysis of routine program data collected October 1, 2021-September 30, 2022, in project-supported sites in Burundi, Côte d'Ivoire, Democratic Republic of Congo, Tanzania, and Togo. We compared HIV case finding (defined as the percentage of children diagnosed with HIV among those who were tested) and treatment initiation (defined as the percentage of children diagnosed with HIV who were initiated on antiretroviral therapy) data for children <15 years disaggregated by index versus non-index testing and CKP versus children of non-KP individuals (non-CKP).

resultsA total of 5,651 children were tested (n = 2,974 index testing; n = 2,677 non-index testing). Of those diagnosed with HIV, 33% (181/541) were CKP, with case finding 17% (181 positive/1,070 tested) among CKP and 8% among non-CKP (360 positive/4,581 tested). Almost half of CKP diagnosed were ages 1-4 years. Among the 2,974 (53%) reached through index testing, overall case finding was higher among CKP (17%; 178 positive/1,052 tested) than non-CKP (11%; 219 positive/1,922 tested). Treatment initiation was 97% among CKP and 94% among non-CKP. DISCUSSION: CKP were identified primarily through index testing which, although considered a priority strategy to identify children at high risk, has not been widely used within KP family networks. Most CKP reached were children of female sex workers, but those of other KPs should also be prioritized.

conclusionsKP-focused programs have often excluded children, but the case-finding approaches in the project's KP programs were effective in reaching CKP. Comprehensive, family-centered KP programming is needed that includes family planning, prevention of vertical transmission, early infant diagnosis, and other maternal and child health services to reduce the impact of HIV on families and achieve an HIV-free generation.

Indexed as

HIV InfectionsAdolescentBurundiChildChild, PreschoolCote d'IvoireDemocratic Republic of the CongoFemaleHIV TestingHumansInfantMaleRetrospective StudiesRisk FactorsTanzaniaTogo

Identifiers

PMID39240901
PMCPMC11379237

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.